Foundation Medicine and Other Categories
At this point, Foundation Medicine is exclusively an oncology company, but our next-generation sequencing technique, which can deep sequence hundreds of genes with world?class laboratory capability and world?class computational biology capability, certainly has potential applicability.
Immunotherapy comes to mind. Immunotherapy, now, is an up?and?coming area of cancer therapy.
We will start to look at immune genes and immune therapy. This could have applicability to autoimmune diseases, for instance, outside of cancer. I think the answer is “Yes, this technique could very well be valuable in diseases other than cancer.”